SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 17.16 |
| Enterprise Value ($M) | 10.27 |
| Book Value ($M) | 12.73 |
| Book Value / Share | 0.75 |
| Price / Book | 1.35 |
| NCAV ($M) | 3.91 |
| NCAV / Share | 0.23 |
| Price / NCAV | 4.39 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.71 |
| Return on Assets (ROA) | -0.77 |
| Return on Equity (ROE) | -1.31 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 4.90 |
| Current Ratio | 4.90 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 16.04 |
| Assets | 24.86 |
| Liabilities | 12.13 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.65 |
| Operating Income | -16.89 |
| Net Income | -18.40 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -17.49 |
| Cash from Investing | -0.53 |
| Cash from Financing | 3.47 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Armistice Capital, Llc | 4.99 | 3.01 | |
| 13G/A | Lind Global Fund II LP | 4.20 | ||
| 13D | Nantahala Capital Management, LLC | 11.80 | 0.00 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 4,868 | 43,987 | 11.07 | |
| 29,954 | 130,852 | 22.89 | |
| 6,275 | 79,757 | 7.87 | |
| 16,141 | 120,831 | 13.36 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| TBPH – Theravance Biopharma, Inc. | TCRX – TScan Therapeutics, Inc. |
| TKNO – Alpha Teknova, Inc. | TNGX – Tango Therapeutics, Inc. |
| TRDA – Entrada Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io